IGF1 and non-small cell lung carcinoma: Abundant data garnered from clinical studies have confirmed that increased serum IGF-1 and/or decreased IGFBP-3 levels are risk factors for growth, invasion and metastasis of many malignancies, including NSCLC (9), colon (10) and breast cancer (11).